A nurse is reinforcing education to a client who has mitral valve stenosis that has not responded to pharmacological therapies. Which of the following statements should the nurse include in their teaching about other treatment options?

Mitral valve stenosis is characterized by structural narrowing of the mitral orifice, obstructing left atrial emptying during diastole. This restriction increases left atrial pressures, driving pulmonary venous congestion and exertional dyspnea. When pharmacological interventions fail to manage symptoms, mechanical intervention like percutaneous balloon valvuloplasty is indicated. This procedure utilizes an endovascular approach to split fused mitral commissures and restore normal luminal dimensions. A. "A flexible catheter will be inserted into a vessel of the arm, neck, or groin and advanced to the heart to dilate a narrowed or occluded artery.": This statement describes percutaneous coronary intervention, which targets atherosclerotic blockages within the coronary arteries to treat myocardial ischemia. It does not address structural valvular narrowing or restore laminar flow across stenotic cardiac leaflets. It isolates arterial rather than valvular pathology. B. "A heparin bolus is administered and followed with a continuous infusion to help keep the blood thinner.": Intravenous heparin infusions provide systemic anticoagulation to prevent thrombus propagation in acute coronary syndromes or deep vein thrombosis. While anticoagulation minimizes embolic risks in stenotic states, it does not mechanically correct or alter the physical valvular restriction. It is a supportive, not corrective, treatment. C. "A small catheter with a balloon on the end is threaded into a vessel in the groin and advanced to the heart where the balloon will be inflated, and the narrowed valve will be dilated.": This accurately outlines a percutaneous balloon mitral valvuloplasty, where a balloon catheter splits calcified commissures to decrease the trans-valvular pressure gradient. This mechanical dilation directly expands the stenotic orifice, reducing backward pulmonary venous pressures. It represents a standard, minimally invasive intervention. D. "Pentoxifylline can be administered to help the platelets from sticking together and occluding the vessels.": Pentoxifylline is a xanthine derivative that alters erythrocyte rheology and decreases blood viscosity, primarily utilized to manage intermittent claudication in peripheral artery disease. It possesses no therapeutic efficacy in reversing mechanical valvular narrowing or reducing left atrial pressure overloads. It lacks relevance to valvular stenosis.